Navigation Links
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids
Date:5/31/2008

re than 100 million American adults have elevated total cholesterol. Of the 30 million Americans currently on lipid-altering therapies, the majority are not reaching treatment goals. Treatment guidelines endorsed by the National Cholesterol Education Panel, the American College of Cardiology and the AHA have called for more aggressive management of lipids, including a lower LDL goal for many patients, as well as more aggressive management of HDL and triglycerides.

About the Study

The efficacy and safety of TriLipix in combination with rosuvastatin was evaluated in a randomized, double-blind, controlled, 12-week, Phase III study of 1,445 patients with mixed dyslipidemia. Patients included in the study had multiple lipid problems, with an LDL greater than or equal to 130 mg/dL, triglycerides greater than or equal to 150 mg/dL and HDL less than 40 mg/dL for men and less than 50 mg/dL for women.

Patients were randomized to receive TriLipix (135mg) combined with either 10mg or 20mg of rosuvastatin, TriLipix monotherapy (135mg) or rosuvastatin monotherapy (10mg, 20mg or 40mg). The 40mg rosuvastatin monotherapy arm was included in the study to assess safety and adverse events, but was not included in the statistical analysis.

The primary efficacy comparisons were mean percent change in HDL and triglycerides in the combination compared to rosuvastatin monotherapy, and mean percent change in LDL in the combination compared to TriLipix monotherapy. The study met all of its primary endpoints. Patients treated with the combination of TriLipix 135mg and rosuvastatin 10mg had an increase in HDL of 20.3 percent and decrease in triglycerides of 47.1 percent compared to an HDL increase of 8.5 percent and triglyceride decrease of 24.4 percent with rosuvastatin 10mg alone. LDL decreased 37.2 percent with the combination compared to 6.5 percent with TriLipix 135mg monotherapy.

Patients treated with the combination of TriLipix 135mg and rosuvastatin 20
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Conn. , June 18, 2013  It ... clients of Alliance Seating and Mobility, a subsidiary ... to access timely repair. This appears to be ... dramatic reduction of field service employees.  ... a great many of these clients are complex ...
(Date:6/18/2013)... LEANDRO, Calif. , June 18, 2013  Cataracts ...  According to the American Association of Ophthalmology, aging is ... a clouding of the eye,s natural lens. 22 million ... 2020, as Baby Boomers continue to age, that number ... high tech world of iPhones, iPads, smart-phones and computers, ...
(Date:6/18/2013)... Mass. , June 18, 2013  Decision ... advisory firms for pharmaceutical and healthcare issues, announces ... coverage of the Middle East ... Access Tracker analyzes the challenges and opportunities to ... four international regions comprising 24 countries. The countries ...
Breaking Medicine Technology:New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3
... , SEOUL, South Korea, Nov. 17 ... Securities Dealers Association Quotation System ("Arigene") (KOSDAQ: 067850), today announced ... announced merger agreement dated October 2, 2009 with Trimeris, Inc. ... of the expiration date of the tender offer being conducted ...
... , MARCY L,ETOILE, France, Nov. 17 bioMerieux ... test to help clinicians select the most appropriate treatment for ... emerging biomarkers, will be intended for use in both adjuvant ... 500,000 new cases of breast cancer are diagnosed each year ...
Cached Medicine Technology:Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 2Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 3Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 4bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment 2bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment 3
(Date:6/19/2013)... 2013 Indosoft Inc., developers of ... for Asterisk, announced today the availability of its ... offers improved options for extracting, consolidating and presenting ... contact center management. , Large Asterisk based contact ... it happens from the call center software. This ...
(Date:6/19/2013)... CoachingWebsites, the leading ... today its affiliation with Active Intelligence. ... websites and marketing solutions and capitalize on affiliate ... with Active Intelligence shows our overall dedication to ... says Greer Van Dyck, Online Marketing Expert at ...
(Date:6/19/2013)... 19, 2013 The Mesothelioma Victims ... Control of the 2500 to 3000 citizens, who will ... mesothelioma this year, about one third will be US ... diagnosed with this asbestos exposure form of cancer, or ... access to the nations most skilled mesothelioma compensation settlement ...
(Date:6/19/2013)... Francisco, CA (PRWEB) June 19, 2013 ... accelerating throughout 2013 across all industries as cash rich ... Despite the differences across industries, all M&A transactions have ... rigorous due diligence to verify the history and quality ... carefully considered. , But when due diligence involves ...
(Date:6/18/2013)... oBand Surgery Centers, a reputed name ... weight loss seminars in Los Angeles this month. Scheduled ... at their official website. oBand Surgery Centers are an ... highly skilled panel of surgeons and dedicated staff has ... senior executive working with oBand Surgery Centers said, “We ...
Breaking Medicine News(10 mins):Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2Health News:CoachingWebsites (Websites for Coaches) Announces Their Partnership With Active Intelligence, LLC 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2
... lowering LDL cholesterol (“bad” cholesterol) to below 100 milligrams ... cholesterol-lowering drug is safe and results in fewer cardiovascular ... They initially took 10 milligrams of atorvastatin (Lipitor) a ... milligrams per deciliter a day or lower. Then, half ...
... A study conducted in Spain has focused on the ... which might be associated with an increased risk of ... during pregnancy has been proven to have disastrous effects ... period, and obstetric complications such as extra uterine pregnancy, ...
... gradually increased recommendations for daily calcium intake, largely from ... to promote healthy bones and prevent osteoporosis. But a ... of milk or other dairy products was not necessarily ... of at least 400 milligrams per day. ,Other ...
... also hide within the body for long periods of time, ... resistance is lowered. The latent infections thus pose repeated problems ... study researchers say a compound found in licorice is showing ... virus that lingers in the body. For the study researchers ...
... suffering from the bone-thinning disease osteoporosis may also be ... condition in which people have a difficult time digesting ... improve bone mineral density, or BMD, among patients with ... have thinning bones, but little study exists to suggest ...
... new way to boost stem cell research that will help ... a new way of growing human embryonic stem cells in ... potential to play an important role in regeneration of cells ... these are exposed to live animal cells and serum and ...
Cached Medicine News:
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
More than 200 key diagnostic and treatment tables culled from Tierney's Current Medical Diagnostics and Treatment 2003....
Consists of the print and PDA versions of Harrison's Manual of Medicine 15th Edition. Provides high-end medical content via PDA....
... BD Safety Knife with BD Xstar Blade ... that protects the blade in prodedure and ... based on a grind-less process for manufacturing ... outstanding sharpness and consistency. The arch ...
Medicine Products: